Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)

Abstract

Literature review of anemia pathogenesis in patients with lymphatic system malignancies is presented. Advantages and disadvanta ges of eritropoiesis-stimulating preparations (ESP) used for anemia correction are shown. Efficacy of anemia treatment with ESP in various types of lymphoproliferative disorders (LPD) is presented. Prognostic factors that predict positive response on ESP in LPD pati ents and reduce treatment cost are identified.

Keywords

• anemic syndrome
• non Hodgkin’s lymphomas
• lymphoproliferative disorders
• multiple myeloma
• anemia treatment
• erythropoietin
• erythropoiesis-stimulating agents
• cytokine
• chemotherapy
• red blood cell transfusion